Proximagen Company
Proximagen is a neuroscience research company developing drugs for neurodegenerative disorders, including Parkinson’s and Alzheimers.
Last Funding Type:
Venture - Series Unknown
Funding Status:
N/A
Headquarters:
London, England, United Kingdom
Founded Date:
2003
Investor Type:
Company
Investment Stage:
N/A
Total Funding:
$96.5M
Technology:
Others
Employee Number:
11-50
Number Of Exists:
Venture - Series Unknown
Estimated Revenue:
$1M to $10M
Investors Number:
1
Industry:
PharmTech